Axtinib in treatment metastatic renal cell carcinoma

Article Properties
  • DOI (url)
    10.36290/xon.2016.018
  • Publication Date
    2016/05/01
  • Journal
    Onkologie
  • Indian UGC (journal)
  • Refrences
    13
  • Citations
    2
  • Igor Richter
  • Josef Dvořák
  • Věra Hejzlarová
  • Jiří Bartoš
Cite
Richter, Igor, et al. “Axtinib in Treatment Metastatic Renal Cell Carcinoma”. Onkologie, vol. 10, no. 2, 2016, pp. 76-78, https://doi.org/10.36290/xon.2016.018.
Richter, I., Dvořák, J., Hejzlarová, V., & Bartoš, J. (2016). Axtinib in treatment metastatic renal cell carcinoma. Onkologie, 10(2), 76-78. https://doi.org/10.36290/xon.2016.018
Richter, Igor, Josef Dvořák, Věra Hejzlarová, and Jiří Bartoš. “Axtinib in Treatment Metastatic Renal Cell Carcinoma”. Onkologie 10, no. 2 (2016): 76-78. https://doi.org/10.36290/xon.2016.018.
Richter I, Dvořák J, Hejzlarová V, Bartoš J. Axtinib in treatment metastatic renal cell carcinoma. Onkologie. 2016;10(2):76-8.
Refrences
Title Journal Journal Categories Citations Publication Date
Hledání optimálního algoritmu léčby metastatického nádoru ledvin 2015
NCCN Clinical Practice Guidelines in 2015
In vivo antitumor aktivity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor rand platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship 2003
10.1158/1078-0432.CCR-08-0652
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial British Journal of Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 74 2014
Citations
Title Journal Journal Categories Citations Publication Date
Axitinib Reactions Weekly 2019
The authors' own experience with axitinib in treating metastatic renal cell carcinoma Onkologie 2 2018
Citations Analysis
The first research to cite this article was titled The authors' own experience with axitinib in treating metastatic renal cell carcinoma and was published in 2018. The most recent citation comes from a 2019 study titled Axitinib. This article reached its peak citation in 2019, with 1 citations. It has been cited in 2 different journals. Among related journals, the Onkologie cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year